Forsteo ® (teriparatide)

Forsteo® (teriparatide): Pharmacokinetic Properties

Teriparatide is quickly absorbed from the injection site, has a half-life of approximately 1 hour, and is undetectable in the blood within 3 hours.

Further information on Pharmacokinetic Properties

Absorption and Distribution

The half-life of Forsteo is approximately 1 hour when administered subcutaneously, which reflects the time required for absorption from the injection site. 1

Teriparatide is rapidly and extensively absorbed following subcutaneous injection, with a maximum serum concentration at approximately 30 minutes.2,3

The volume of distribution is approximately 1.7 L/kg.1

Biotransformation and Elimination

No metabolism or excretion studies have been performed with Forsteo but the peripheral metabolism of parathyroid hormone is believed to occur predominantly in liver and kidney.1

Forsteo is eliminated through hepatic and extra-hepatic clearance (approximately 62 L/hr in women and 94 L/hr in men).1

Teriparatide is rapidly eliminated with a decrease to nonquantifiable concentrations within 3 hours of the dose.3


1. Forsteo [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2. Satterwhite J, Heathman M, Miller PD, et al. Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis. Calcif Tissue Int. 2010;87(6):485-492.

3. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Date of Last Review: November 11, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request